NOVOZYMES -B- (NZM2 DU) stock market data APIs
€51.8974
0.01(0%)
as of April 1, 2026
Try our APIs with
free plan!
NOVOZYMES -B- Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NZM2.DU.
Prev. Close
51.8974
Open
51.9104
High
51.9416
Low
51.897
52 wk Range
41.18-64.2313
Market Cap
19 321 M
Dividends (Yield)
0.1097
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NOVOZYMES -B- data using free add-ons & libraries
Get NOVOZYMES -B- Fundamental Data
NOVOZYMES -B- Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NOVOZYMES -B- News
New
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY). But which of these two stocks is more attractive to value inv...
Resolutions from the Annual General Meeting 2026
Novonesis (Novozymes A/S) Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025 Approval...
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
Novonesis (Novozymes A/S) COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction ...
Novonesis issues EUR 1.7 billion senior unsecured notes
Novonesis (Novozymes A/S) On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). Th...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
